Literature DB >> 1981690

Evidence that the agonist action of dynorphin A(1-8) in the guinea-pig myenteric-plexus may be mediated partly through conversion to [Leu5]enkephalin.

D M Dixon1, J R Traynor.   

Abstract

1. The agonist action of the opioid peptide dynorphin A(1-8) on the myenteric plexus-longitudinal muscle of the guinea-pig ileum has been characterized. 2. The endogenous opioid peptide dynorphin A(1-8) was rapidly degraded by slices of myenteric plexus-longitudinal muscle of the guinea-pig ileum. 3. A product of the degradation was the delta-receptor preferring [Leu5]enkephalin. Levels of [Leu5]enkephalin were markedly increased in the presence of the peptidase inhibitors bestatin, thiorphan and captopril. 4. In the myenteric plexus dynorphin A(1-8) acted as a kappa-receptor agonist. In the presence of bestatin, thiorphan and captopril a mu-receptor agonist effect was observed. This mu-agonist action was lost in the presence of N-[1-(RS)-carboxy-2-phenylethyl]Ala-Ala-Phe-p-aminobenzoate, an inhibitor of the endopeptidase enzyme EC 3.4.24.15. 5. The results suggest that formation of [Leu5]enkephalin from dynorphin A(1-8) may be an important conversion process. The enzyme responsible may be the Zn2(+)-metalloendopeptidase, EC 3.4.24.15.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1981690      PMCID: PMC1917763          DOI: 10.1111/j.1476-5381.1990.tb14139.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

1.  Distribution of immunoreactive dynorphin in the central nervous system of the rat.

Authors:  N Zamir; M Palkovits; M J Brownstein
Journal:  Brain Res       Date:  1983-11-28       Impact factor: 3.252

2.  Dynorphin and dynorphin are ligands for the kappa-subtype of opiate receptor.

Authors:  A D Corbett; S J Paterson; A T McKnight; J Magnan; H W Kosterlitz
Journal:  Nature       Date:  1982-09-02       Impact factor: 49.962

3.  Dynorphin is a specific endogenous ligand of the kappa opioid receptor.

Authors:  C Chavkin; I F James; A Goldstein
Journal:  Science       Date:  1982-01-22       Impact factor: 47.728

4.  Specific receptor for the opioid peptide dynorphin: structure--activity relationships.

Authors:  C Chavkin; A Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

5.  Increase in potencies of opioid peptides after peptidase inhibition.

Authors:  A T McKnight; A D Corbett; H W Kosterlitz
Journal:  Eur J Pharmacol       Date:  1983-01-21       Impact factor: 4.432

6.  Active site directed N-carboxymethyl peptide inhibitors of a soluble metalloendopeptidase from rat brain.

Authors:  T G Chu; M Orlowski
Journal:  Biochemistry       Date:  1984-07-31       Impact factor: 3.162

7.  Kappa-binding and degradation of [3H]dynorphin A (1-8) and [3H]dynorphin A (1-9) in suspensions of guinea pig brain membranes.

Authors:  M G Gillan; L E Robson; A T McKnight; H W Kosterlitz
Journal:  J Neurochem       Date:  1985-10       Impact factor: 5.372

8.  Spectrum of the mu, delta- and kappa-binding sites in homogenates of rat brain.

Authors:  M G Gillan; H W Kosterlitz
Journal:  Br J Pharmacol       Date:  1982-11       Impact factor: 8.739

9.  Opioid receptor selectivity of dynorphin gene products.

Authors:  I F James; W Fischli; A Goldstein
Journal:  J Pharmacol Exp Ther       Date:  1984-01       Impact factor: 4.030

10.  The time course of synaptic potentials evoked in cat spinal motoneurones at identified group Ia synapses.

Authors:  S Redman; B Walmsley
Journal:  J Physiol       Date:  1983-10       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.